Titelia

Holdings of Venrock Adviser, LLC

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
29 in 2 countries
Top ten
75.8 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Apogee Therapeutics Inc 8,493,321714.9M $
2Erasca Inc 16,382,812265.1M $
3ORUKA THERAPEUTICS INC 4,148,428203.5M $
4Spyre Therapeutics Inc 3,685,448185.9M $
5KalVista Pharmaceuticals Inc 6,474,485130.3M $
6Dianthus Therapeutics Inc 1,180,00099M $
7DAMORA THERAPEUTICS INC 3,603,59593.3M $
8OCULAR THERAPEUTIX INC 10,346,92687.6M $
9COGENT BIOSCIENCES INC 2,000,00077M $
10VIRIDIAN THERAPEUTICS INC 3,882,70975.9M $
11SAVARA INC 13,740,37575M $
12Enliven Therapeutics Inc 1,726,33167.7M $
13ORIC Pharmaceuticals Inc 4,319,76554.7M $
14VOR BIOPHARMA INC 3,041,71954.3M $
15Maze Therapeutics Inc 1,602,03447.8M $
16CYTOMX THERAPEUTICS INC 9,982,12446.9M $
17JADE BIOSCIENCES INC 3,220,36445.2M $
18DYNE THERAPEUTICS INC 2,173,91339.4M $
19Relmada Therapeutics Inc 4,843,38033.7M $
20Tenax Therapeutics Inc 1,675,26226.8M $
21ADLAI NORTYE LTD 3,212,73122.2M $
22Century Therapeutics Inc 8,695,65219.7M $
23Cullinan Therapeutics Inc 1,379,96519.6M $
24Surrozen Inc 632,93118.4M $
25Septerna Inc 506,05612.2M $
26Korro Bio Inc 1,009,50011.4M $
27Alto Neuroscience Inc 500,00011.2M $
28Artiva Biotherapeutics Inc 1,609,56910.4M $
29X4 Pharmaceuticals Inc 330,5251.4M $

Download this table: CSV, JSON

Tell me about updates

Sector breakdown

  • Unattributed 100.0 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 99.1 %
  • Cayman Islands 0.9 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States282.5B $99.13 %
2Cayman Islands122.2M $0.87 %
Cite this page

Titelia. "Holdings of Venrock Adviser, LLC". https://titelia.com/en/funds/US13F1615982